Zhejiang NHU Company (002001) Q4 2025 earnings summary

Executive summary

• Achieved operating revenue of RMB 22.25 billion in 2025, up 2.97% year-over-year; net profit attributable to shareholders rose 15.26% to RMB 6.76 billion.

• Maintained leading positions in vitamins, aroma chemicals, and new materials, with strong global expansion and R&D investment.

• Expanded overseas operations with new subsidiaries and warehouses, and advanced major projects in nutrition, aroma chemicals, and new materials.

Financial highlights

• Operating revenue: RMB 22.25 billion (up 2.97% YoY); net profit: RMB 6.76 billion (up 15.26% YoY).

• Net profit after deducting non-recurring items: RMB 6.74 billion (up 15.59% YoY).

• Basic and diluted EPS: RMB 2.21 (up 15.71% YoY); weighted average ROE: 21.87%.

• Total assets: RMB 45.61 billion (up 6.09% YoY); net assets: RMB 32.81 billion (up 11.87% YoY).

• Net cash flows from operating activities: RMB 8.80 billion (up 24.38% YoY).

Outlook and guidance

• Focus on expanding markets, driving innovation, and empowering operations with intelligent manufacturing.

• Plans to strengthen synergy in R&D, production, supply, and sales, accelerate new product R&D, and enhance risk management.

• Targets continued global expansion, high-quality growth in core businesses, and further integration of ESG and carbon reduction.